Aveo Pharmaceuticals Inc
NASDAQ:AVEO
Aveo Pharmaceuticals Inc
Net Change in Cash
Aveo Pharmaceuticals Inc
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aveo Pharmaceuticals Inc
NASDAQ:AVEO
|
Net Change in Cash
$8.6m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Net Change in Cash
$11.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Change in Cash
-$218m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Change in Cash
-$21.9B
|
CAGR 3-Years
-140%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Change in Cash
-$126.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Change in Cash
-$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aveo Pharmaceuticals Inc's Net Change in Cash?
Net Change in Cash
8.6m
USD
Based on the financial report for Sep 30, 2022, Aveo Pharmaceuticals Inc's Net Change in Cash amounts to 8.6m USD.
What is Aveo Pharmaceuticals Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
17%
Over the last year, the Net Change in Cash growth was -70%. The average annual Net Change in Cash growth rates for Aveo Pharmaceuticals Inc have been -39% over the past three years , 17% over the past five years .